VIB and VUB researchers involved in Innovative Medicines Initiative that awards 30 Million Euro grant supporting research into novel tracer strategies for clinical imaging of immune cell dynamics.

The Innovative Medicines Initiative Joint Undertaking (IMI2 JU) project ‘Immune-Image’ has been launched. Immune cells will be studied in vivo using non-invasive and clinically applicable high-end imaging techniques including Positron Emission Tomography (PET), Optical Imaging (OI) and Magnetic Resonance Imaging (MRI). The teams of Nick Devoogdt (VUB) and Jo Van Ginderachter (VIB-VUB) are involved in this endeavour.

Jo Van Ginderachter​

The introduction of immunotherapeutic drugs for the treatment of cancer and inflammatory disease, where the drugs encourage the body’s own immune system to attack the disease, have had a significant impact. However, immunotherapies do not work for all patients. Immune-Image will develop methods to visualize and study the immune cells involved before, during, and after such treatments allowing selection of the right treatment for the right patient and at the right time. The information obtained about the immune cells and their activity during disease could be used to develop new drugs that might help those patients for which current immunotherapies are ineffective.

More on www.immune-image.eu